Singapore markets close in 4 hours 41 minutes
Straits Times Index
3,301.49 +8.80 (+0.27%) Nikkei
38,281.40 +7.35 (+0.02%) Hang Seng
18,155.28 +392.25 (+2.21%) FTSE 100
8,121.24 -22.89 (-0.28%) Bitcoin USD
57,389.22 -2,831.34 (-4.70%) CMC Crypto 200
1,260.65 -78.41 (-5.86%)
BioMarin Pharmaceutical Inc. (BMRN)
NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
After hours:
Currency in USD
Valuation measures4
| Market cap (intra-day) | 15.82B |
| Enterprise value | 15.87B |
| Trailing P/E | 78.61 |
| Forward P/E | 31.35 |
| PEG ratio (5-yr expected) | 0.71 |
| Price/sales (ttm) | 6.50 |
| Price/book (mrq) | 3.12 |
| Enterprise value/revenue | 6.42 |
| Enterprise value/EBITDA | 44.18 |
Trading information
Stock price history
| Beta (5Y monthly) | 0.32 |
| 52-week change 3 | -12.70% |
| S&P500 52-week change 3 | 23.57% |
| 52-week high 3 | 99.56 |
| 52-week low 3 | 76.02 |
| 50-day moving average 3 | 87.21 |
| 200-day moving average 3 | 89.00 |
Share statistics
| Avg vol (3-month) 3 | 1.58M |
| Avg vol (10-day) 3 | 2.29M |
| Shares outstanding 5 | 189.88M |
| Implied shares outstanding 6 | 189.88M |
| Float 8 | 188.42M |
| % held by insiders 1 | 0.84% |
| % held by institutions 1 | 100.82% |
| Shares short (15 Apr 2024) 4 | 3.69M |
| Short ratio (15 Apr 2024) 4 | 2.76 |
| Short % of float (15 Apr 2024) 4 | 1.96% |
| Short % of shares outstanding (15 Apr 2024) 4 | 1.94% |
| Shares short (prior month 15 Mar 2024) 4 | 2.96M |
Dividends & splits
| Forward annual dividend rate 4 | N/A |
| Forward annual dividend yield 4 | N/A |
| Trailing annual dividend rate 3 | 0.00 |
| Trailing annual dividend yield 3 | 0.00% |
| 5-year average dividend yield 4 | N/A |
| Payout ratio 4 | 0.00% |
| Dividend date 3 | N/A |
| Ex-dividend date 4 | N/A |
| Last split factor 2 | N/A |
| Last split date 3 | N/A |
Financial highlights
Fiscal year
| Fiscal year ends | 31 Dec 2023 |
| Most-recent quarter (mrq) | 31 Mar 2024 |
Profitability
| Profit margin | 8.31% |
| Operating margin (ttm) | 12.09% |
Management effectiveness
| Return on assets (ttm) | 1.77% |
| Return on equity (ttm) | 4.22% |
Income statement
| Revenue (ttm) | 2.47B |
| Revenue per share (ttm) | 13.12 |
| Quarterly revenue growth (yoy) | 8.80% |
| Gross profit (ttm) | N/A |
| EBITDA | 293.47M |
| Net income avi to common (ttm) | 205.46M |
| Diluted EPS (ttm) | 1.06 |
| Quarterly earnings growth (yoy) | 74.40% |
Balance sheet
| Total cash (mrq) | 1.05B |
| Total cash per share (mrq) | 5.51 |
| Total debt (mrq) | 1.1B |
| Total debt/equity (mrq) | 21.61% |
| Current ratio (mrq) | 2.74 |
| Book value per share (mrq) | 26.74 |
Cash flow statement
| Operating cash flow (ttm) | 280.16M |
| Levered free cash flow (ttm) | 64.45M |
© 2024 Yahoo. All rights reserved.